Legal Opinion
In re Relafen Antitrust Litigation
District Court, D. Massachusetts
Decided May 12, 2004No. MASTER FILE NO. 01-12239-WGYPublishedCited by 61 opinions
1Opinion of the Court
MEMORANDUM
YOUNG, Chief Judge.
I. INTRODUCTION
On November 21, 2003, this Court issued an order allowing the End Payor Plaintiffs’ Motion for Class Certification with respect to two exemplar classes certified under Rule 23(b)(3). Order of 11/21/03 [Doc. No. 168]. This memorandum details the analysis that led to that order.
II. BACKGROUND
This case presents a consolidated action against SmithKline Beecham Corporation and GlaxoSmithKline PLC (collectively “SmithKline”) for violations of the antitrust laws related to its patent for the chemical compound nabumetone, which it sells commercially as…
2Cases cited125 opinions
- Erie Railroad v. TompkinsSupreme Court of the United States · 1938
- Warth v. SeldinSupreme Court of the United States · 1975
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- General Telephone Co. of Southwest v. FalconSupreme Court of the United States · 1982
- Eisen v. Carlisle & JacquelinSupreme Court of the United States · 1974
120 more not listed; retrieve them via the Exa API.
3Cited by61 opinions
- Mahon v. Ticor Title Insurance CompanyCourt of Appeals for the Second Circuit · 2012
- In re Pharmaceutical Industry Average Wholesale Price LitigationDistrict Court, D. Massachusetts · 2005
- In re Wellbutrin XL Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2009
- In Re Graphics Processing Units Antitrust LitigationDistrict Court, N.D. California · 2007
- In Re New Motor Vehicles Canadian Export Antitrust LitigationDistrict Court, D. Maine · 2004
56 more not listed; retrieve them via the Exa API.